Molecular Neurobiology,
Journal Year:
2025,
Volume and Issue:
unknown
Published: Jan. 16, 2025
Demyelination
is
commonly
observed
in
neurodegenerative
disorders,
including
multiple
sclerosis
(MS).
Biotin
supplementation
known
to
stabilize
MS
progression.
To
reduce
the
effective
dose
of
biotin,
we
synthesized
a
new
and
superior
form
complex
magnesium
ionically
bound
biotin
(MgB)
compared
its
dose-dependent
effect
with
alone
after
inducing
demyelination
using
lysolecithin
(LPC)
rats.
Myelination
was
assessed
luxol
fast
blue
staining
immunostaining
against
MBP
protein,
revealing
that
most
significant
remyelination
occurred
MgB
groups.
Additionally,
both
MgB-treated
animals
showed
improvements
spatial
memory.
Moreover,
detected
decrease
inflammatory
proteins
treatment
groups,
which
more
prominent
high-dose
correlated
decreased
expression
NF-κB
p65,
OP,
MMP-9
proteins.
Further
analysis
biotin-related
demonstrated
and,
notably,
reversed
demyelination-dependent
reduction
these
Furthermore,
particularly
MgB,
improved
neuronal
transmission
proteins,
Synapsin-1,
PSD-93,
PSD-95.
groups
exhibited
increased
BDNF,
GAP43,
ICAM
levels,
increments
animals.
Increased
GFAP,
indicative
reactive
gliosis,
LPC-treated
animals,
this
notably
by
treatment.
The
current
data
emphasize
beneficial
on
process.
combination
Mg
resulted
potent
itself.
strong
influence
encourages
proof-of-concept
studies
patients
MS.
Translational Neurodegeneration,
Journal Year:
2023,
Volume and Issue:
12(1)
Published: Jan. 26, 2023
Alzheimer's
disease
(AD)
is
associated
with
metabolic
abnormalities
linked
to
critical
elements
of
neurodegeneration.
We
recently
administered
combined
activators
(CMA)
the
AD
rat
model
and
observed
that
CMA
improves
AD-associated
histological
parameters
in
animals.
promotes
mitochondrial
fatty
acid
uptake
from
cytosol,
facilitates
oxidation
mitochondria,
alleviates
oxidative
stress.
International Journal of Molecular Sciences,
Journal Year:
2023,
Volume and Issue:
24(4), P. 3739 - 3739
Published: Feb. 13, 2023
Neurodegenerative
diseases
comprise
a
wide
spectrum
of
pathologies
characterized
by
progressive
loss
neuronal
functions
and
structures.
Despite
having
different
genetic
backgrounds
etiology,
in
recent
years,
many
studies
have
highlighted
point
convergence
the
mechanisms
leading
to
neurodegeneration:
mitochondrial
dysfunction
oxidative
stress
been
observed
pathologies,
their
detrimental
effects
on
neurons
contribute
exacerbation
pathological
phenotype
at
various
degrees.
In
this
context,
increasing
relevance
has
acquired
antioxidant
therapies,
with
purpose
restoring
order
revert
damage.
However,
conventional
antioxidants
were
not
able
specifically
accumulate
diseased
mitochondria,
often
eliciting
harmful
whole
body.
last
decades,
novel,
precise,
mitochondria-targeted
(MTA)
compounds
developed
studied,
both
vitro
vivo,
address
need
counter
mitochondria
restore
energy
supply
membrane
potentials
neurons.
review,
we
focus
activity
therapeutic
perspectives
MitoQ,
SkQ1,
MitoVitE
MitoTEMPO,
most
studied
belonging
class
MTA
conjugated
lipophilic
cations,
reach
compartment.
International Journal of Molecular Sciences,
Journal Year:
2021,
Volume and Issue:
22(21), P. 11847 - 11847
Published: Oct. 31, 2021
As
the
population
ages,
incidence
of
neurodegenerative
diseases
is
increasing.
Due
to
intensive
research,
important
steps
in
elucidation
pathogenetic
cascades
have
been
made
and
significantly
implicated
mitochondrial
dysfunction
oxidative
stress.
However,
available
treatment
Alzheimer’s
disease,
Parkinson’s
amyotrophic
lateral
sclerosis
mainly
symptomatic,
providing
minor
benefits
and,
at
most,
slowing
down
progression
disease.
Although
preclinical
setting,
drugs
targeting
stress
yielded
encouraging
results,
clinical
trials
failed
or
had
inconclusive
results.
It
likely
that
by
time
diagnosis,
are
full-blown
significant
numbers
neurons
already
degenerated,
making
it
impossible
for
mitochondria-targeted
antioxidant
molecules
stop
reverse
process.
Until
further
research
will
provide
more
efficient
molecules,
a
healthy
lifestyle,
with
plenty
dietary
antioxidants
avoidance
exogenous
oxidants
may
postpone
onset
neurodegeneration,
while
familial
cases
benefit
from
genetic
testing
aggressive
therapy
started
stage.
Biomedicines,
Journal Year:
2022,
Volume and Issue:
10(6), P. 1432 - 1432
Published: June 17, 2022
Huntington's
disease
is
an
inherited
neurodegenerative
described
150
years
ago
by
George
Huntington.
The
genetic
defect
was
identified
in
1993
to
be
expanded
CAG
repeat
on
exon
1
of
the
huntingtin
gene
located
chromosome
4.
In
following
almost
30
years,
a
considerable
amount
research,
using
mainly
animal
models
or
vitro
experiments,
has
tried
unravel
complex
molecular
cascades
through
which
transcription
mutant
protein
leads
neuronal
loss,
especially
medium
spiny
neurons
striatum,
and
excitotoxicity,
transcriptional
dysregulation,
mitochondrial
dysfunction,
oxidative
stress,
impaired
proteostasis,
altered
axonal
trafficking
reduced
availability
trophic
factors
crucial
contributors.
This
review
discusses
pathogenic
literature
demise.
However,
due
ubiquitous
presence
huntingtin,
astrocytes
are
also
dysfunctional,
neuroinflammation
may
additionally
contribute
pathology.
quest
for
therapies
delay
onset
reduce
rate
progression
ongoing,
but
based
findings
from
basic
research.
Antioxidants,
Journal Year:
2022,
Volume and Issue:
11(11), P. 2167 - 2167
Published: Oct. 31, 2022
Alzheimer’s
disease
(AD),
the
most
common
form
of
dementia,
has
increasing
incidence,
mortality
rates,
and
poses
a
huge
burden
on
healthcare.
None
currently
approved
drugs
for
treatment
AD
influence
progression.
Many
clinical
trials
aiming
at
inhibiting
amyloid
plaque
formation,
beta
clearance,
or
neurofibrillary
tangle
pathology
yielded
inconclusive
results
failed.
Meanwhile,
research
identified
many
interlinked
vicious
cascades
implicating
oxidative
stress,
mitochondrial
dysfunction,
chronic
neuroinflammation,
pointed
to
novel
therapeutic
targets
such
as
improving
bioenergetics
quality
control,
diminishing
modulating
neuroinflammatory
pathways.
molecules
tested
in
vitro
animal
models
have
proven
efficient,
but
their
translation
into
clinic
needs
further
regarding
appropriate
doses,
delivery
routes,
possible
side
effects.
Cell-based
therapies
extracellular
vesicle-mediated
messenger
RNAs
microRNAs
seem
also
promising
strategies
allowing
target
specific
signaling
pathways,
need
harvesting
culture
methods
well
control
tumorigenic
The
rapidly
developing
area
nanotechnology
could
improve
drug
be
used
early
diagnosis.
International Journal of Molecular Sciences,
Journal Year:
2022,
Volume and Issue:
24(1), P. 543 - 543
Published: Dec. 29, 2022
According
to
Alzheimer’s
Disease
International,
55
million
people
worldwide
are
living
with
dementia.
Dementia
is
a
disorder
that
manifests
as
set
of
related
symptoms,
which
usually
result
from
the
brain
being
damaged
by
injury
or
disease.
The
symptoms
involve
progressive
impairments
in
memory,
thinking,
and
behavior,
accompanied
emotional
problems,
difficulties
language,
decreased
motivation.
most
common
variant
dementia
disease
dominated
cognitive
disorders,
particularly
memory
loss,
impaired
personality,
judgmental
disorders.
So
far,
all
attempts
treat
dementias
removing
their
rather
than
causes
have
failed.
Therefore,
presented
narrative
review,
I
will
attempt
explain
etiology
perspective
energy
metabolism
dysfunction
an
aging
brain.
hope
this
perspective,
though
perhaps
too
simplified,
bring
us
closer
essence
aging-related
neurodegenerative
disorders
soon
allow
develop
new
preventive/therapeutic
strategies
our
struggle
dementia,
disease,
Parkinson’s
Biology,
Journal Year:
2022,
Volume and Issue:
11(6), P. 943 - 943
Published: June 20, 2022
Insulin
was
discovered
and
isolated
from
the
beta
cells
of
pancreatic
islets
dogs
is
associated
with
regulation
peripheral
glucose
homeostasis.
produced
in
brain
related
to
synaptic
plasticity
memory.
Defective
insulin
signaling
plays
a
role
dysfunction,
such
as
neurodegenerative
disease.
Growing
evidence
suggests
link
between
metabolic
disorders,
diabetes
obesity,
diseases,
especially
Alzheimer’s
disease
(AD).
This
association
due
common
state
resistance
(IR)
mitochondrial
dysfunction.
review
takes
journey
into
past
summarize
what
known
about
physiological
pathological
tissues
brain.
Then,
it
will
land
present
analyze
on
health
effects
diseases
that
are
IR-dependent.
Specifically,
we
focus
our
attention
quality
control
mitochondria
(MQC),
dynamics,
biogenesis,
selective
autophagy
(mitophagy),
healthy
altered
cases.
Finally,
this
be
projected
toward
future
by
examining
most
promising
treatments
target
cure
disorders.
Frontiers in Cellular Neuroscience,
Journal Year:
2023,
Volume and Issue:
17
Published: June 2, 2023
Neurons
maintain
their
average
firing
rate
and
other
properties
within
narrow
bounds
despite
changing
conditions.
This
homeostatic
regulation
is
achieved
using
negative
feedback
to
adjust
ion
channel
expression
levels.
To
understand
how
of
excitability
normally
works
it
goes
awry,
one
must
consider
the
various
channels
involved
as
well
regulated
impacted
by
adjusting
those
when
regulating
excitability.
raises
issues
degeneracy
pleiotropy.
Degeneracy
refers
disparate
solutions
conveying
equivalent
function
(e.g.,
different
combinations
yielding
excitability).
many-to-one
mapping
contrasts
one-to-many
described
pleiotropy
affecting
multiple
properties).
facilitates
enabling
a
disturbance
be
offset
compensatory
changes
in
any
several
or
thereof.
Pleiotropy
complicates
because
intended
regulate
property
may
inadvertently
disrupt
properties.
Co-regulating
pleiotropic
requires
greater
than
isolation
and,
extension,
can
fail
for
additional
reasons
such
each
being
incompatible
with
another.
Problems
also
arise
if
perturbation
too
strong
and/or
weak,
set
point
disturbed.
Delineating
loops
interactions
provides
valuable
insight
into
might
fail.
Insofar
failure
modes
require
distinct
interventions
restore
homeostasis,
deeper
understanding
its
pathological
disruption
reveal
more
effective
treatments
chronic
neurological
disorders
like
neuropathic
pain
epilepsy.
Cellular and Molecular Life Sciences,
Journal Year:
2023,
Volume and Issue:
80(7)
Published: June 24, 2023
Abstract
Ageing
is
characterized
by
the
progressive
loss
of
cellular
homeostasis,
leading
to
an
overall
decline
organism’s
fitness.
In
brain,
ageing
highly
associated
with
cognitive
and
neurodegenerative
diseases.
With
rise
in
life
expectancy,
characterizing
brain
process
becomes
fundamental
for
developing
therapeutic
interventions
against
increased
incidence
age-related
diseases
aim
increase
human
span
and,
more
importantly,
health
span.
this
review,
we
start
introducing
molecular/cellular
hallmarks
their
impact
on
cell
populations.
Subsequently,
assess
emerging
evidence
how
systemic
translates
into
ageing.
Finally,
revisit
mainstream
novel
rejuvenating
strategies,
discussing
most
successful
ones
delaying
related